NO149471C - Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater - Google Patents

Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater

Info

Publication number
NO149471C
NO149471C NO784325A NO784325A NO149471C NO 149471 C NO149471 C NO 149471C NO 784325 A NO784325 A NO 784325A NO 784325 A NO784325 A NO 784325A NO 149471 C NO149471 C NO 149471C
Authority
NO
Norway
Prior art keywords
tetracyclonon
pharmasoyytic
derivatives
preparing
active
Prior art date
Application number
NO784325A
Other languages
English (en)
Other versions
NO149471B (no
NO784325L (no
Inventor
Douglas Lintin Swallow
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NO784325L publication Critical patent/NO784325L/no
Publication of NO149471B publication Critical patent/NO149471B/no
Publication of NO149471C publication Critical patent/NO149471C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/19Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45Monoamines
    • C07C211/48N-alkylated amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/86Ring systems containing bridged rings containing four rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO784325A 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater NO149471C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5344677 1977-12-22

Publications (3)

Publication Number Publication Date
NO784325L NO784325L (no) 1979-07-27
NO149471B NO149471B (no) 1984-01-16
NO149471C true NO149471C (no) 1984-04-25

Family

ID=10467839

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784325A NO149471C (no) 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater

Country Status (20)

Country Link
US (2) US4357352A (no)
EP (1) EP0002896B1 (no)
JP (1) JPS5490167A (no)
AT (1) AT363923B (no)
AU (1) AU517387B2 (no)
CA (1) CA1118792A (no)
CS (1) CS208769B2 (no)
DD (1) DD140843A5 (no)
DE (1) DE2861796D1 (no)
DK (1) DK150299C (no)
ES (1) ES476241A1 (no)
FI (1) FI66347C (no)
HU (1) HU177222B (no)
IL (1) IL56167A (no)
IT (1) IT1110868B (no)
NO (1) NO149471C (no)
NZ (1) NZ189087A (no)
PT (1) PT68974A (no)
SU (1) SU1156591A3 (no)
YU (1) YU40544B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822158B (no) * 1980-12-30 1984-10-01
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids
JPS63188770U (no) * 1987-05-25 1988-12-05
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
US5645988A (en) * 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
US20030225044A1 (en) * 2002-06-03 2003-12-04 Bachman Stephen E. Method to increase serum levels of vitamins in animals including humans

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418368A (en) * 1965-03-24 1968-12-24 Smith Kline French Lab Pentacyclo[6.2.0.02,6.03,10.05,9] decaneamines
US3456008A (en) * 1965-10-11 1969-07-15 Smithkline Corp Aminopolycyclodecanes
CH472364A (de) 1966-12-22 1969-05-15 Geigy Ag J R Verfahren zur Herstellung eines neuen polycyclischen Amins
US3496228A (en) * 1967-02-16 1970-02-17 Smithkline Corp Aminotricyclononanes and the salts thereof

Also Published As

Publication number Publication date
HU177222B (en) 1981-08-28
CA1118792A (en) 1982-02-23
SU1156591A3 (ru) 1985-05-15
DK150299C (da) 1987-10-26
PT68974A (en) 1979-01-01
IL56167A (en) 1982-09-30
JPS6214539B2 (no) 1987-04-02
JPS5490167A (en) 1979-07-17
DK560278A (da) 1979-06-23
IT7852360A0 (it) 1978-12-19
AU4224178A (en) 1979-06-28
NO149471B (no) 1984-01-16
CS208769B2 (en) 1981-09-15
FI783948A (fi) 1979-06-23
FI66347C (fi) 1984-10-10
DD140843A5 (de) 1980-04-02
US4454157A (en) 1984-06-12
YU303778A (en) 1983-01-21
YU40544B (en) 1986-02-28
IL56167A0 (en) 1979-03-12
EP0002896B1 (en) 1982-05-05
NO784325L (no) 1979-07-27
FI66347B (fi) 1984-06-29
US4357352A (en) 1982-11-02
ATA913078A (de) 1981-02-15
EP0002896A1 (en) 1979-07-11
NZ189087A (en) 1980-11-14
ES476241A1 (es) 1979-04-16
AT363923B (de) 1981-09-10
DE2861796D1 (en) 1982-06-24
AU517387B2 (en) 1981-07-30
DK150299B (da) 1987-02-02
IT1110868B (it) 1986-01-06

Similar Documents

Publication Publication Date Title
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE7808485L (sv) Forfarande for framstellning av oligoimider
NO781769L (no) Fremgangsmaate for fremstilling av hoeyredreiende spiro-hydantoinforbindelser
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO782769L (no) Fremgangsmaate for fremstilling av ammoniakk
NO783134L (no) Fremgangsmaate for fremstilling av ammoniakk
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
SE7807240L (sv) Forfarande for framstellning av para-bensokinon
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
NO152220C (no) Fremgangsmaate for fremstilling av sesquiterpenderivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO791604L (no) Fremangsmaate for fremstilling av di-o-n-alkyl-glycerolderivater
SE428686B (sv) Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
NO149471C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater